PARALLEL SESSION 2.4

Similar documents
Identifying, Preparing for & Reducing Pandemic Risk

Global and Regional Strategies for HPAI and CSF

APEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006

USDA APHIS One Health Initiative

Emerging global health threats of animal origin

Preventing disease Promoting and protecting health

FAO component of the USAID EPT-2 programme

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

Humanitarian Logistics & Pandemic Influenza

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

VNN. FAO Viet Nam s Emergency Centre for. Newsletter. FAO Viet Nam

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

Advanced Lecture on One Health

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Regional Cooperation Initiatives: FAO Updates Food and Agriculture Organization of the United Nations Regional Office for Asia and the Pacific

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

SECTOR ASSESMENT (SUMMARY): HEALTH

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

July 24, Dr. Dennis Carroll Global Health Bureau Director, Global Health Security and Development. Emerging Threats Program

Public Safety and Health Cooperation from the Canadian Perspective

EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

GLOBAL HEALTH SECURITY AGENDA ROADMAP VIETNAM

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response

Adjunct Faculty, Division of Epidemiology UC Berkeley School of Public Health. San Francisco Department of Public Health.

The Western Pacific Region faces significant

FAO contribution to the OFFLU swine influenza group

Whole Of Society Approach To Preparedness

Copenhagen, Denmark, September August Malaria

The OIE World Animal Health and Welfare Fund

16 th JPC REM ESA M ohammedia 18-19th April Surveillance of low pathogenic Avian Influenza virus

Pandemic Influenza Preparedness and Response

FAO s Animal Health Initiatives in Asia and the Pacific. 9th Regional Steering Committee Meeting of GF TADs for Asia and Pacific

IHR News. The WHO quarterly bulletin on IHR implementation. 30 June 2009, No. 7

THE UNREGULATED AND INFORMAL TRADE IN WILDLIFE: IMPLICATIONS FOR BIODIVERSITY AND HEALTH

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Health in Europe: A Strategic Approach

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

Egypt Success Story In Combating Avian Influenza

Health Task Force Workplan

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and

Mapping the Global Virome. Making the Unknown Known. And the World Safe From a Future of Viral Threats

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Ebola: preparedness and solidarity. Ebola virus disease has claimed more than lives. and infected more than people in West Africa

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

CONCEPT NOTE. surveillance, prevention and risk mitigation of Animal Influenza and other Transboundary Animal Diseases

OIE Activities in support of One Health

HEALTH. Infectious Diseases HIV/AIDS

Readiness for Microbial Threats 2030: Exploring Lessons Learned since the 1918 Influenza Pandemic A Workshop

OIE Situation Report for Highly Pathogenic Avian Influenza

2/26/2018. Deadliest Enemy: Our War Against Killer Germs

Dr. Alejandro Schudel Fundación PROSAIA Argentina. 17 th IMS World Meat Congress Cape Town, South Africa, 7-10 September 2008

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

Five Major Challenges for Pandemic Prediction and Prevention

PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between

CDC s Global Disease Detection Program

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Presentation to Building Continuity conference. 5 May Steve Brazier Director of Emergency Management

Emily Kahn, PhD, MPH, MA

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Antimicrobial resistance Fact sheet N 194 Updated April 2014

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide

USAID s approach to the control of avian and pandemic influenza

OIE Situation Report for Avian Influenza

Prevention and Control of Emerging Infections. Mediadora C Saniel, MD, MBA-H Infectious Disease Practice and Innovations The Medical City

Pandemic Preparedness Communications: WHO

SECOND FAO/OIE REGIONAL MEETING ON AVIAN INFLUENZA CONTROL IN ASIA Ho Chi Minh City, Vietnam, February 2005

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

Improving the Response to Public Health Emergencies

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30)

Global Health Security: Preparedness and Response: can we do better and stay safe?

Avian Influenza Intersectoral Collaboration

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update


County of Los Angeles Department of Health Services Public Health

AVIAN INFLUENZA. USAID Strategy

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Assignment Description

Disease Prevention, Detection & Response During Public Health Emergencies

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Influenza Pandemic: Overview of Ops Response. Ministry of Health SINGAPORE

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

The Current Status of the Epidemiologic Transition

Yellow fever. Key facts

Pandemic Influenza: U.S. Government Perspective on International Issues

An example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)

Pandemic Influenza: Hype or Reality?

PARALLEL SESSION 1.1

Leaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015

Richmond, Virginia. Assignment Description

Before and during influenza pandemics

Transcription:

PARALLEL SESSION 2.4 CHANGING DYNAMICS: EMERGING INFECTIOUS DISEASES AND ANTIMICROBIAL RESISTANCE IN AN ERA OF EXPANDING GLOBAL HUMAN POPULATION GROWTH AND MOVEMENT

BACKGROUND The global human population is projected to peak at over 11 billion this century. Accelerated human population growth and corresponding changes in demography, along with associated food and companion animal population increases, are altering disease dynamics and will continue to drive emerging infections and transmission over the course of the next century. This session will explore the connections among infectious disease emergence, antimicrobial resistance (AMR), and changing human and animal population dynamics. We will explore the state-of-the-art in emerging disease and AMR detection and forecasting and answer the question, How can we minimize emerging disease and AMR risks linked to changing demography. OBJECTIVES This session aims to explore and address the impacts of growing human and animal populations and unplanned mega-cities and peri-urban settlements on disease emergence, amplification, and global distribution. Accordingly, presenters will also tackle the risks associated with surging global trade and travel and illustrate how forecasting can inform risk mitigation. Specific Objectives: Explore projected demographic trends over the 21st century and their impact on expected zoonotic disease emergence and AMR Enhance understanding of how trends in demography will differ regionally; how differences in agricultural productivity and marketing practices will impact emerging disease risk, including spread of AMR; and how purchasing power and animal protein demand will have global supply chain impacts and associated emerging disease risk Highlight practical, evidence-driven approaches to defining, forecasting, and mitigating human demographic-driven emerging disease risk

Moderator Jonna Mazet Professor Medicine & Epidemiology University of California at Davis United States of America Jonna Mazet, DVM, MPVM, PhD, is a Professor of Epidemiology and Disease Ecology and Executive Director of the One Health Institute in the UC Davis School of Veterinary Medicine, where she focuses on global health problem solving, especially for emerging infectious disease and conservation challenges. Dr. Mazet is active in international One Health research programs, most notably in relation to disease transmission among wildlife, domestic animals, and people and the ecological drivers of disease emergence. Currently, she is the Global Director of a $175 million viral emergence early warning project, named PREDICT, that has been developed with the US Agency for International Development s (USAID) Emerging Pandemic Threats Program. She was elected to the US National Academy of Medicine in 2013 in recognition of her successful and innovative approach to emerging environmental and global health threats and serves on the National Academies Forum on Microbial Threats, as well as chairs the Academies One Health Work Group.

Christine Johnson Professor and Researcher UC Davis United States of America Christine Kreuder Johnson is Professor of Epidemiology and Associate Director of the One Health Institute in the School of Veterinary Medicine at UC Davis where she directs the EpiCenter for Disease Dynamics. Her research activities focus on zoonotic disease spillover and spread dynamics, epidemiologic drivers of zoonotic disease transmission, ecosystem level processes that impact wildlife population health and emerging infectious diseases, and mechanisms underlying species declines. She provides epidemiologic support to national and state agencies during unusual outbreak events and has developed and implemented risk-based approaches for surveillance and standardized risk assessment to enable systematic data analysis across a range of field studies from the local to global scale. At UC Davis, her accomplishments include the design of core didactic instruction in one health, ecosystem health, and population health for graduate and professional degree programs and primary mentorship to over 45 graduate students and post-doctoral scholars. Since 2009, Professor Johnson has served as epidemiologist for USAID s Emerging Pandemic Threats PREDICT project, optimizing global surveillance activities to identify infectious disease threats at high-risk animal-human interfaces and working with host country governments and international organizations to meet global health priorities. Since 2014, she has directed surveillance activities for PREDICT to implement concurrent animal and human sample and data collection needed to detect disease spillover, amplification, and spread and inform risk mitigation strategies.

Evelyn Wesangula Coordinator Global Antibiotic Resistance Partnership Kenya Evelyn is a pharmacist with an Msc. in Tropical and infectious Diseases who has over ten years experience at the Ministry of Health in Kenya. She has successfully championed the development of the National Policy and Action Plan for Antimicrobial Resistance in Kenya from a multi-sectoral perspective. She has been key in the implementation of infection prevention and control (IPC) interventions, antimicrobial resistance (AMR) surveillance activities, and antibiotic stewardship and awareness programs at a national level. As a member of the infection prevention and control team at the National Level within the Ministry of Health and she has supported the development and implementation of the National Infection Prevention and Control Guidelines and a national training curriculum for basic infection prevention and control for health care settings. Evelyn has organized antibiotic awareness weeks for five consecutive years in Kenya. This contributed to the establishment of the AMR program within the Ministry of Health. This year she will support the development of the National antimicrobial stewardship guidelines for Kenya. She has worked as a consultant with the World Health Organization on developing guidance on establishing and sustaining multi-sectoral collaboration to support implementation of the National Action Plans and was recently appointed as a member of the Fleming Fund Technical Advisory Group. She is currently pursuing her PHD on antimicrobial stewardship at the University of Nairobi, School of Pharmacy. Evelyn is committed to overcoming barriers, work with partners within and from outside her country to sustain changes that will reduce the burden of AMR in Kenya.

Katrin Kohl Deputy Director Division of Global Migration and Quarantine Centers for Disease Control and Prevention United States of America Biosketch Dr. Katrin Kohl Dr. Katrin Kohl is Deputy Director of the Division of Global Migration and Quarantine in the National Center for Emerging and Zoonotic Infectious Diseases at the U.S. Centers for Disease Control and Prevention. Dr. Kohl provides leadership to domestic and international programs that address health issues and threats related to international travel, importation of infectious diseases into the United States, and mobile populations through the Division s 5 organizational units: Quarantine and Border Health Services, Traveler s Health, Immigrant, Refugee and Migrant Health, Community Interventions for Infection Control, and a U.S.-Mexico Binational Unit. Dr. Kohl co-leads the implementation of the International Health Regulations at the Centers for Disease Control and Prevention in close collaboration with the World Health Organization, the Department of Health and Human Services, and the U.S. state health departments. Dr. Kohl was involved in leadership roles in numerous CDC-wide responses including the 2009 H1N1 influenza pandemic, the 2014 importation of MERS Coronavirus to the U.S., the 2014 Ebola virus disease outbreak in West Africa, and the 2015 Zika outbreak. Her primary focus is the mitigation of disease importation and exportation through travelers. Dr. Kohl obtained a medical degree and a PhD in Cardiology from the Free University of Berlin, Germany and a Master in Public Health and a Diploma in Tropical Medicine from Tulane School of Public Health and Tropical Medicine in New Orleans, USA. In 1997, Dr. Kohl joined the Centers for Disease Control and Prevention as an Epidemic Intelligence Services Officer based in Louisiana, completed a Preventive Medicine Residency at CDC in the Division of Sexually Transmitted Diseases, led a large vaccine safety team including building a global vaccine safety collaboration, and joined her current Division in 2006.

Saber Yezli The Global Centre for Mass Gatherings Medicine, Public Health Directorate Ministry of Health Saudi Arabia Dr Saber Yezli is the Head of Research at the Global Centre for Mass Gatherings Medicine, a WHO collaborating center on Mass Gatherings Medicine. He obtained his first class BSc (Hons) degree in Genetics in 2003 and his PhD in molecular biology in 2008 from Cardiff University, UK. A pioneer in the emerging field of mass gatherings health, Dr Yezli started his career in the area of hospital acquired infections and antimicrobial resistance to later expand to infectious disease and public health, with particular interest in mass gatherings and mass gatherings health. In the last few years Dr Yezli led numerous Hajj-related research for providing evidence-base for appropriate public health policy making for the event. Dr Yezli is a member of the UK Infection Prevention Society (IPS), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the French Association for Standardization (AFNOR). He served as an associate editor of the Journal of Infection Prevention and the Journal of Epidemiology and Global Health. Dr Yezli is also the author/co-author of numerous peer-reviewed publications, book chapters, abstracts and invited oral presentations.

Thuy Bich Hoang Country Program Director Wildlife Conservation Society Viet Nam Thuy Bich Hoang has a Master degree in Public Management and Economics. She is the director of the Wildlife Conservation Society (WCS)'s Viet Nam program, which is working on the implementation of the USAID EPT-PREDICT - a project that aims to prevent, detect, and rapidly respond to the spillover of novel infectious pathogens from wildlife to humans. Thuy has extensive experience working in partnership with local Government in the human and animal health sectors, including on the prevention of avian influenza and emerging pandemic threats, and wildlife farming and conservation. She is familiar with participatory and competence-based capacity building, behavior change communication interventions to promote more protective practices and mitigate zoonotic risks in human and animals, using these as public health evidence to empower enforcement officers including police, forest rangers, customs, and prosecutors to combat wildlife trafficking. Thuy had also worked with USAID EPT1-PREVENT where she has engaged with different ministries and local partners in Lao PDR, Cambodia and Viet Nam to institutionalize policy change e.g. monitoring biosecurity practices for market improvement and at captive breeding farms.